CE/CME

Mumps–It’s Back!

Clinician Reviews. 2015 April;25(4):24-31

Author(s):

Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.

Expires April 30, 2016

Although overshadowed in the headlines by a sharp increase in measles cases, mumps too is making a comeback, with outbreaks throughout 2014 and early 2015. Many of today’s clinicians have never seen a case of mumps, let alone experienced an outbreak. Here’s what to look for and what to do if mumps makes its appearance in your practice.

PDF Download

References

1. CDC. Mumps cases and outbreaks. www.cdc.gov/mumps/outbreaks.html. Accessed March 19, 2015.
2. CDC. Measles prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1989;38(suppl 9):1-18.
3. CDC. Summary of notifiable diseases—United States. 1993-2012. MMWR Morb Mortal Wkly Rep. www.cdc.gov/mmwr/mmwr_nd/index.html. Accessed March 19, 2015.
4. CDC. Mumps, chap 9. In: Manual for the Surveillance of Vaccine-Preventable Diseases. August 2012. www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.html. Accessed March 19, 2015.
5. Pyle E. Central Ohio mumps outbreak finally loses steam. The Columbus Dispatch. October 11, 2014. www.dispatch.com/content/stories/local/2014/10/10/Health-officials-declare-mumps-outbreak-over.html. Accessed March 19, 2015.
6. Hascup J. Three more mumps cases: Penguins’ Steve Downie, Thomas Greiss, Devils’ Patrik Elias, Michael Ryder. USA TODAY. December 27, 2014. www.usatoday.com/story/sports/nhl/2014/12/26/steve-downie-thomas-greiss-mumps-pittsburgh-penguins/20911031/. Accessed March 19, 2015.
7. Idaho public health officials warn that mumps outbreak involving University students has spread to Boise and State of Washington [news release]. Boise, ID: Idaho Department of Health and Welfare Public Information Office; February 6, 2015. www.healthandwelfare.idaho.gov/AboutUs/Newsroom/tabid/130/ctl/ArticleView/mid/3061/articleId/1819/Idaho-Public-Health-Officials-Warn-that-Mumps-Outbreak-Involving-University-Students-Has-Spread-to-Boise-and-State-of-Washington.aspx. Accessed March 19, 2015.
8. CDC. Epidemiology and prevention of vaccine-preventable diseases. Mumps, chap 12. In: The Pink Book: Course Textbook. 12th ed, 2012. www.cdc.gov/vaccines/pubs/pinkbook/mumps.html. Accessed March 19, 2015.
9. Albrecht MA. Epidemiology, clinical manifestations, diagnosis, and management of mumps. www.uptodate.com/contents/epidemiology-clin ical-manifestations-diagnosis-and-management-of-mumps. Accessed March 19, 2015.
10. Defendi GL. Mumps. http://reference.medscape.com/article/966678-overview. Accessed March 19, 2015.
11. CDC. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR04):1-34.
12. Rubin S, Carbone KM. Mumps. In: Longo DL, Fauci AS, Kasper DL et al, eds. Harrison’s Principles of Internal Medicine. 18th ed. New York, NY: The McGraw-Hill Companies, Inc.; 2012:chap 194.
13. Dayan G, Quinlisk M, Parker A, et al. Recent resurgence of mumps in the United States. New Engl J Med. 2008;358:1580-1589.
14. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2010: Objectives for Improving Health. www.healthypeople.gov/2010/Document/HTML/Volume1 /14Immunization.htm#_Toc494510239. Accessed March 19, 2015.
15. CDC. Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47(RR-8):1-57.
16. Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ. 2005;(330):1132-1135.
17. CDC. Laboratory testing for mumps infection. www.cdc.gov/mumps/lab/qa-lab-test-infect.html. Accessed March 19, 2015.
18. Barskey AE, Schulte C, Rosen JB, et al. Mumps outbreak in Orthodox Jewish communities in the United States. New Engl J Med. 2012;367(18): 1704-1713.
19. CDC. Frequently asked questions about measles in the U.S. www.cdc.gov/measles/about/faqs.html. Accessed March 19, 2015.
20. Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014;168(2):148-155.
21. LeBaron CW, Forghani B, Beck C, et al. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis. 2009; 199(4):552-560.
22. Anis E, Grotto I, Moerman L, et al. Mumps outbreak in Israel’s highly vaccinated society: are two doses enough? Epidemiol Infect. 2012; 140:439-446.
23. Sane J, Gouma S, Koopmans M, et al. Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis. 2014;20(4):643-648.
24. CDC. Exposure and response. www.cdc.gov/mumps/clinical/qa-exposure-response.html. Accessed March 19, 2015.
25. CDC. Mumps prevention and control in healthcare settings. www.cdc.gov/mumps/prev-control-settings/background.html. Accessed March 19, 2015.
26. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgence in the United States: a historical perspective on unexpected elements. Vaccine. 2009;27:6186-6195.
27. Ogbuanu IU, Kutty PK, Hudson JM, et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics. 2012;130:e1567-e1574.
28. CDC. Physical findings and complications. www.cdc.gov/mumps/clinical/qa-physical-complic.html. Accessed March 19, 2015.
29. Conniff R. A forgotten pioneer of vaccines. The New York Times. May 6, 2013. www.nytimes.com/2013/05/07/health/maurice-hilleman-mmr-vaccines-forgotten-hero.html?_r=0. Accessed March 19, 2015.
30. CDC. MMR vaccine for mumps. www.cdc.gov/vaccines/vpd-vac/mumps/vac-faqs-tech.htm. Accessed March 19, 2015.
31. The College of Physicians of Philadelphia. The history of vaccines. www.historyofvaccines.org/content/timelines/all. Accessed March 19, 2015.
32. CDC. Travelers’ health. Mumps. wwwnc.cdc.gov/travel/diseases/mumps. Accessed March 19, 2015.
33. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children [retracted in Lancet. 2010;375:445]. Lancet. 1998;351:637-641.
34. Murch SH, Anthony A, Casson DH, et al. Retraction of an interpretation. Lancet. 2004;363(9411):750.
35. Deer B. How the case against the MMR vaccine was fixed. BMJ. 2011;342:1-16.
36. The Editors of The Lancet. Notice of retraction of "Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children" [retraction of: Wakefield AJ, Murch SH, Anthony A, et al. In: Lancet. 1998;351:637-641]. Lancet. 2010;375:445.
37. Whalen J. UK bans doctor who linked autism to vaccine. The Wall Street Journal. May 24, 2010. www.wsj.com/articles/SB10001424052748704113504575263994195318772. Accessed March 19, 2015.
38. CDC. Vaccine safety: measles, mumps and rubella (MMR) vaccine. www.cdc.gov/vaccinesafety/vaccines/mmr/mmr.html. Accessed March 19, 2015.
39. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347:1477-1482.
40. DeStefano F, Bhasin TK, Thompson WW, et al. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics. 2004;113(2):259-266.
41. Richler J, Luyster R. Risi S, et al. Is there a ‘regressive phenotype’ of autism spectrum disorder associated with the measles-mumps-rubella vaccine? A CPEA study. J Autism Dev Disord. 2006;36(3):299-316.
42. Nyhan B, Reifler J, Richey S, Freed G. Effective messages in vaccine promotion: a randomized trial. Pediatrics. 2014:133:1-8.
43. Haberman C. A discredited vaccine study’s continuing impact on public health. The New York Times. February 1, 2015. www.nytimes.com/2015/02/02/us/a-discredited-vaccine-studys-continuing-impact- on-public- health.html?_r=0. Accessed March 19, 2015.